FEMY FEMASYS INC

$3.04 -1.30%

Updated 17 d ago

Healthcare · Surgical & Medical Instruments & Apparatus

FEMASYS INC (FEMY) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $25 million. Shares last traded at $3.04, 87.2% below their 52-week high. Over the past year the stock is down 59.0%. Net profit margin is -511.8%, below the peer median of -9.3%. Revenue grew 40.8% year over year.

Market Cap

$25M

Shares Out

8.4M

EPS (TTM)

$-9.30

P/E Ratio

—

P/S Ratio

11.07

P/B Ratio

6.32

Dividend / Share

—

Dividend Yield

—

52-Week High

$23.80

52-Week Low

$2.04

Volume

1,396

Avg Vol (3m)

9,669.214

Performance

+7.04%

+0.33%

-57.00%

-70.68%

YTD

-75.92%

-58.97%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · split-adjusted · Databento EQUS.MINI. FEMY split history →

Technicals

RSI (14)

50.31

SMA (50)

$3.20

SMA (200)

$8.84

Price vs SMA50

-5.11%

Price vs SMA200

-65.60%

ATR (14)

$0.33

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue

$2M

Net Income

$-12M

Gross Margin

60.9%

Operating Margin

-763.9%

Net Margin

-511.8%

Return on Equity

-291.9%

Return on Assets

-95.8%

Current Ratio

2.14

Debt / Equity

2.05

Revenue Growth (YoY)

+40.8%

Latest reported annual period ending 2026-06-30 · SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

Period	EPS (diluted)	Reported
Q2 2026	$-1.08	2026-08-14
Q1 2026	$0.00	2026-05-08
FY 2025	$-0.47	2026-03-31
Q3 2025	$-0.46	2025-11-14
Q2 2026	$-7.76	2026-08-14
Q1 2026	$-0.23	2026-05-08

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

FEMY vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap. Updated 17 d ago

P/S vs peers

11.07 / 2.94 med

+277% premium

Net margin vs peers

-511.8% / -9.3% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.2B	31.69	4.57	14.4%	-1.31%
MMM	3M	$86.8B	28.97	3.45	11.9%	-0.28%
BSX	Boston Scientific	$68.0B	18.54	3.24	17.5%	-3.17%
BDX	Becton Dickinson	$51.1B	54.30	2.45	4.5%	+0.00%
DXCM	DexCom	$33.9B	33.86	6.81	20.1%	+0.02%
RMD	ResMed	$33.1B	21.70	5.85	26.9%	-0.78%
MDLN	Medline Inc.	$30.7B	—	1.08	—	+0.88%
WST	West Pharmaceutical Services	$24.1B	42.67	7.25	17.0%	+0.00%
SOLV	Solventum	$15.7B	10.97	1.89	17.3%	+0.56%
BAX	Baxter International	$13.2B	-12.44	1.15	-9.3%	-0.51%
PEN	Penumbra Inc	$12.7B	78.81	9.02	11.4%	-0.46%
GKOS	Glaukos Corp	$10.6B	-56.59	17.36	-30.7%	+0.52%
GMED	Globus Medical Inc	$10.5B	19.59	3.34	17.0%	-3.14%
PODD	Insulet Corporation	$10.4B	27.82	3.42	12.3%	+1.63%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.